AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home Genes & Diseases Article
PDF (219.4 KB)
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Correspondence | Open Access

Correspondence (reply): The application conditions of false discovery rate control

Hongbin Zhang1,, Xin Le2, Tingxiu Xiang3( )
Cancer Center, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing 400042, China
Department of Oncology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China
Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing 400030, China

Peer review under responsibility of Chongqing Medical University.

Show Author Information

References

1

Zhang H, Xu K, Xiang Q, et al. LPCAT1 functions as a novel prognostic molecular marker in hepatocellular carcinoma. Genes Dis. 2022;9(1):151-164.
Crossref Google Scholar
2

Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Stat Soc Ser B Methodol. 1995;57(1):289-300.
Crossref Google Scholar
3

Curran-Everett D. Multiple comparisons: philosophies and illustrations. Am J Physiol Regul Integr Comp Physiol. 2000;279:R1-R8.
Crossref Google Scholar
Genes & Diseases
Volume 10 Issue 4,
July 2023
Pages 1145-1146
DOI: 10.1016/j.gendis.2022.11.011
Cite this article:
Zhang H, Le X, Xiang T. Correspondence (reply): The application conditions of false discovery rate control. Genes & Diseases, 2023, 10(4): 1145-1146. https://doi.org/10.1016/j.gendis.2022.11.011

291

Views

7

Downloads

0

Crossref

0

Web of Science

0

Scopus

0

CSCD

Altmetrics
Received: 01 November 2022
Published: 25 October 2023
© 2022 The Authors.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Return